focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Shire plc

19 Dec 2018 11:04

FORM 8.3

AMENDMENT TO s2(a) AND PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Millennium International Management LP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Shire plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

17th December 2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

Yes, Takeda Pharmaceutical Company Limited

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 5p ordinary (JE00B2QKY057) - interest [partially] held via holding of ADRs and ADR Options (US82481R1068)

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 4,871,427 0.531% 234,600 0.026%
(2) Cash-settled derivatives: 3,490,204 0.381% 4,844 0.001%
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 910,000 0.099% 240,000 0.013%

TOTAL:

9,271,631 1.006% 479,444 0.040%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit (USD)
US82481R1068 Sale 100 169.00
US82481R1068 Sale 430 169.12
US82481R1068 Sale 700 169.19
US82481R1068 Sale 500 169.28
US82481R1068 Sale 160 169.37
US82481R1068 Sale 200 169.40
US82481R1068 Sale 300 169.41
US82481R1068 Sale 300 169.43
US82481R1068 Sale 2,489 169.48
US82481R1068 Sale 500 169.49
US82481R1068 Sale 2,360 169.51
US82481R1068 Sale 200 169.55
US82481R1068 Sale 996 169.65
US82481R1068 Sale 300 169.68
US82481R1068 Sale 188 169.73
US82481R1068 Sale 100 169.77
US82481R1068 Sale 200 169.78
US82481R1068 Sale 200 169.86
US82481R1068 Sale 200 170.09
US82481R1068 Sale 100 170.20
US82481R1068 Sale 719 170.23
US82481R1068 Sale 700 170.24
US82481R1068 Sale 600 170.30
US82481R1068 Sale 100 170.31
US82481R1068 Sale 668 170.34
US82481R1068 Sale 152 170.40
US82481R1068 Sale 400 170.41
US82481R1068 Sale 860 170.44
US82481R1068 Sale 260 170.45
US82481R1068 Sale 400 170.50
US82481R1068 Sale 250 170.51
US82481R1068 Sale 200 170.56
US82481R1068 Sale 500 170.64
US82481R1068 Sale 200 170.65
US82481R1068 Sale 1,021 170.70
US82481R1068 Sale 100 170.71
US82481R1068 Sale 948 170.72
US82481R1068 Sale 300 170.73
US82481R1068 Sale 100 170.74
US82481R1068 Sale 320 170.75
US82481R1068 Sale 600 170.76
US82481R1068 Sale 400 170.77
US82481R1068 Sale 100 170.78
US82481R1068 Sale 400 170.79
US82481R1068 Sale 100 170.80
US82481R1068 Sale 1,400 170.81
US82481R1068 Sale 100 170.82
US82481R1068 Sale 500 170.84
US82481R1068 Sale 100 170.85
US82481R1068 Sale 1,239 170.86
US82481R1068 Sale 710 170.87
US82481R1068 Sale 346 170.88
US82481R1068 Sale 4,509 170.91
US82481R1068 Sale 900 170.92
US82481R1068 Sale 1,000 170.93
US82481R1068 Sale 1,844 170.94
US82481R1068 Sale 100 170.95
US82481R1068 Sale 100 170.96
US82481R1068 Sale 300 170.98
US82481R1068 Sale 274 171.00
US82481R1068 Sale 150 171.01
US82481R1068 Sale 275 171.04
US82481R1068 Sale 514 171.06
US82481R1068 Sale 300 171.08
US82481R1068 Sale 100 171.09
US82481R1068 Sale 110 171.11
US82481R1068 Sale 100 171.12
US82481R1068 Sale 100 171.15
US82481R1068 Sale 100 171.17
US82481R1068 Sale 220 171.23
US82481R1068 Sale 1,200 171.24
US82481R1068 Sale 41 171.25
US82481R1068 Sale 500 171.27
US82481R1068 Sale 100 171.28
US82481R1068 Sale 1,596 171.29
US82481R1068 Sale 160 171.30
US82481R1068 Sale 600 171.31
US82481R1068 Sale 205 171.32
US82481R1068 Sale 300 171.33
US82481R1068 Sale 100 171.34
US82481R1068 Sale 700 171.35
US82481R1068 Sale 100 171.36
US82481R1068 Sale 52 171.38
US82481R1068 Sale 1,900 171.40
US82481R1068 Sale 198 171.41
US82481R1068 Sale 1,279 171.45
US82481R1068 Sale 100 171.49
US82481R1068 Sale 800 171.50
US82481R1068 Sale 850 171.51
US82481R1068 Sale 200 171.52
US82481R1068 Sale 200 171.54
US82481R1068 Sale 1,060 171.55
US82481R1068 Sale 300 171.65
US82481R1068 Sale 700 171.69
US82481R1068 Sale 203 171.71
US82481R1068 Sale 800 171.76
US82481R1068 Sale 294 171.79
US82481R1068 Sale 750 171.83
US82481R1068 Sale 1,600 171.88
US82481R1068 Sale 600 171.89
US82481R1068 Sale 300 171.94
US82481R1068 Sale 500 172.00
US82481R1068 Sale 200 172.02
US82481R1068 Sale 100 172.06
US82481R1068 Sale 100 172.07
US82481R1068 Sale 100 172.11
US82481R1068 Sale 300 172.12
US82481R1068 Purchase 100 170.02
US82481R1068 Purchase 4,969 170.08
US82481R1068 Purchase 39 170.26
US82481R1068 Purchase 161 170.30
US82481R1068 Purchase 200 170.32
US82481R1068 Purchase 100 170.55
US82481R1068 Purchase 178 170.63
US82481R1068 Purchase 100 170.64
US82481R1068 Purchase 101 170.65
US82481R1068 Purchase 287 170.69
US82481R1068 Purchase 122 170.70
US82481R1068 Purchase 100 170.72
US82481R1068 Purchase 100 170.73
US82481R1068 Purchase 200 170.78
US82481R1068 Purchase 100 170.80
US82481R1068 Purchase 95 170.82
US82481R1068 Purchase 159 170.83
US82481R1068 Purchase 904 170.91
US82481R1068 Purchase 100 170.94
US82481R1068 Purchase 800 170.97
US82481R1068 Purchase 195 171.06
US82481R1068 Purchase 341 171.15
US82481R1068 Purchase 200 171.20
US82481R1068 Purchase 100 171.23
US82481R1068 Purchase 298 171.25
US82481R1068 Purchase 100 171.38
US82481R1068 Purchase 130 171.41
US82481R1068 Purchase 580 171.50
US82481R1068 Purchase 992 171.60
US82481R1068 Purchase 100 171.71
US82481R1068 Purchase 205 171.78
US82481R1068 Purchase 100 171.99
US82481R1068 Purchase 200 172.01
US82481R1068 Sale 274 169.26
US82481R1068 Sale 300 169.29
US82481R1068 Sale 100 169.31
US82481R1068 Sale 100 169.32
US82481R1068 Sale 100 169.36
US82481R1068 Sale 100 169.37
US82481R1068 Sale 100 169.47
US82481R1068 Sale 100 169.49
US82481R1068 Purchase 119 168.93
US82481R1068 Purchase 3 168.99
US82481R1068 Purchase 44 169.17
US82481R1068 Purchase 15 169.21
US82481R1068 Purchase 9 169.29
US82481R1068 Purchase 6 169.34
US82481R1068 Purchase 408 169.47
US82481R1068 Purchase 1,000 169.57
US82481R1068 Purchase 2,712 169.59
US82481R1068 Purchase 6 169.77
US82481R1068 Purchase 3 169.87
US82481R1068 Purchase 199 170.06
US82481R1068 Purchase 30 170.08
US82481R1068 Purchase 150 170.11
US82481R1068 Purchase 100 170.12
US82481R1068 Purchase 100 170.17
US82481R1068 Purchase 15 170.20
US82481R1068 Purchase 2,000 170.26
US82481R1068 Purchase 3 170.45
US82481R1068 Purchase 9 170.46
US82481R1068 Purchase 462 170.48
US82481R1068 Purchase 198 170.57
US82481R1068 Purchase 417 170.59
US82481R1068 Purchase 27 170.66
US82481R1068 Purchase 3 170.70
US82481R1068 Purchase 444 170.73
US82481R1068 Purchase 190 170.78
US82481R1068 Purchase 300 170.79
US82481R1068 Purchase 700 170.80
US82481R1068 Purchase 497 170.81
US82481R1068 Purchase 700 170.82
US82481R1068 Purchase 235 170.83
US82481R1068 Purchase 200 170.86
US82481R1068 Purchase 236 170.87
US82481R1068 Purchase 124 170.92
US82481R1068 Purchase 12 170.94
US82481R1068 Purchase 204 170.97
US82481R1068 Purchase 15 170.98
US82481R1068 Purchase 24 171.00
US82481R1068 Purchase 200 171.03
US82481R1068 Purchase 100 171.07
US82481R1068 Purchase 439 171.08
US82481R1068 Purchase 100 171.11
US82481R1068 Purchase 307 171.17
US82481R1068 Purchase 6 171.20
US82481R1068 Purchase 3 171.23
US82481R1068 Purchase 6 171.26
US82481R1068 Purchase 9 171.32
US82481R1068 Purchase 212 171.34
US82481R1068 Purchase 12 171.40
US82481R1068 Purchase 100 171.41
US82481R1068 Purchase 600 171.42
US82481R1068 Purchase 213 171.43
US82481R1068 Purchase 1,215 171.45
US82481R1068 Purchase 200 171.48
US82481R1068 Purchase 6 171.50
US82481R1068 Purchase 294 171.51
US82481R1068 Purchase 418 171.52
US82481R1068 Purchase 400 171.53
US82481R1068 Purchase 100 171.54
US82481R1068 Purchase 300 171.57
US82481R1068 Purchase 300 171.61
US82481R1068 Purchase 100 171.62
US82481R1068 Purchase 100 171.64
US82481R1068 Purchase 100 171.69
US82481R1068 Purchase 200 171.70
US82481R1068 Purchase 1,700 171.72
US82481R1068 Purchase 100 171.73
US82481R1068 Purchase 194 171.79
US82481R1068 Purchase 167 171.80
US82481R1068 Purchase 1,700 171.86
US82481R1068 Purchase 68 171.91
US82481R1068 Purchase 248 171.96
US82481R1068 Purchase 1,700 172.05
US82481R1068 Purchase 1,700 172.08
US82481R1068 Purchase 100 172.19
US82481R1068 Purchase 1,700 172.23
US82481R1068 Sale 115 170.17
US82481R1068 Sale 100 170.84
US82481R1068 Sale 112 171.96

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit(GBP)
JE00B2QKY057 CFD Closing a long position 552,977 45.41
JE00B2QKY057 CFD Reducing a long position 23,569 45.42
JE00B2QKY057 CFD Reducing a long position 421,128 45.42
JE00B2QKY057 CFD Reducing a long position 48,508 45.42
JE00B2QKY057 CFD Closing a long position 159,249 45.42
JE00B2QKY057 CFD Increasing a short position 290 45.29
JE00B2QKY057 CFD Closing a short position 37,734 45.42
JE00B2QKY057 CFD Reducing a short position 41,493 45.42
JE00B2QKY057 CFD Opening a long position 652,454 45.42
JE00B2QKY057 CFD Increasing a long position 552,977 45.41
JE00B2QKY057 CFD Decreasing a long position 4,844 45.42
JE00B2QKY057 CFD Decreasing a long position 37,734 45.42
JE00B2QKY057 CFD Decreasing a long position 41,493 45.42
JE00B2QKY057 CFD Increasing a long position 33,749 45.31
JE00B2QKY057 CFD Decreasing a long position 29,918 45.50
JE00B2QKY057 CFD Decreasing a long position 20,694 45.72
JE00B2QKY057 CFD Decreasing a long position 20,082 45.77
JE00B2QKY057 CFD Increasing a long position 4,952 45.46
JE00B2QKY057 CFD Increasing a long position 1,350 45.49
JE00B2QKY057 CFD Decreasing a long position 1,087 45.53
JE00B2QKY057 CFD Decreasing a long position 840 45.70
JE00B2QKY057 CFD Decreasing a long position 3,500 45.32
JE00B2QKY057 CFD Increasing a long position 25,334 45.25
JE00B2QKY057 CFD Increasing a long position 12,400 45.25

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 18th December 2018
Contact name: Milos Naumovic
Telephone number: +44 203 650 8203

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Full name of person making disclosure: Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates: Shire plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security Product description e.g. call option Written or purchased Number of securities to which option or derivative relates Exercise price per unit Type

e.g. American, European etc.

Expiry date
US82481R1068 Call Option Purchased 360,000 180

USD

American 18.1.2019
US82481R1068 Put Option Purchased 120,000 4,200 GBP American 21.12.2018
US82481R1068 Call Option Purchased 120,000 4,400GBP American 15.3.2019
US82481R1068 Put Option Purchased 120,000 4,800GBP American 15.3.2019
US82481R1068 Call Option Purchased 250,000 5,200GBP American 18.1.2018
US82481R1068 Call Option Purchased 180,000 190 USD American 21.12.2018

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181219005312/en/

Copyright Business Wire 2018

Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.